Given that adipocytes are sufficient to drive tumor progression (Nieman et al. 2011; Huang et al. 2017; Wu et al. 2019), we sought to assess the relevance of SHP2/PDHA/ROS to adipocyte-driven cellular hallmarks of PDAC. This evidence concerns the gene PTPN11 and neoplasm.